Blog

EU regulator backs approval for GSK injectable asthma drug

(Reuters) – GlaxoSmithKline Plc said the European health regulator had recommended an approval for its injectable drug to treat asthma patients who don’t respond well to traditional inhalers. The European Commission is expected to decide on a final approval for the drug, Nucala, before the end of 2015. Nucala, a monthly injection, is also being tested for the treatment of chronic obstructive pulmonary disease, a respiratory disorder often associated with